Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sherri, Mudri"'
Autor:
Jing Yang, Gary Means, Pamela Holland, Chelsea Gudgeon, Mark Maurer, Sherri Mudri, Lori Blanchfield, Stacey Dillon, Zelanna Goldberg, Stanford Peng
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/c8021284446649e989e2921b9cb13fd1
Autor:
Stacey R. Dillon, Lawrence S. Evans, Katherine E. Lewis, Susan Debrot, Tiffany C. Blair, Sherri Mudri, Kayla Kleist, Steven D. Levin, Janhavi G. Bhandari, Logan Garrett, Martin F. Wolfson, Pamela M. Holland, Mark W. Rixon, Stanford L. Peng
Publikováno v:
Arthritis & Rheumatology.
Autor:
Lawrence S. Evans, Katherine E. Lewis, Daniel DeMonte, Janhavi G. Bhandari, Logan B. Garrett, Joseph L. Kuijper, Daniel Ardourel, Martin F. Wolfson, Susan Debrot, Sherri Mudri, Kayla Kleist, Luana L. Griffin, LuAnne Hebb, Russell J. Sanderson, NingXin Wang, Michelle Seaberg, Allison G. Chunyk, Jing Yang, Youji Hong, Zahra Maria, David J. Messenheimer, Pamela M. Holland, Stanford L. Peng, Mark W. Rixon, Stacey R. Dillon
Publikováno v:
Arthritis & Rheumatology.
Autor:
Z. Goldberg, Pamela M. Holland, Stanford L. Peng, Gary Means, Lori Blanchfield, Mark F. Maurer, Sherri Mudri, Chelsea J. Gudgeon, Stacey R. Dillon, Jing Yang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPreclinical evidence supports combining checkpoint inhibition (CPI) with T cell costimulatory agonism to improve the breadth and durability of anti-tumor responses relative to CPI alone. Currently, there are a number of therapeutic approach
Autor:
Jing Yang, Steven D. Levin, Bruce R. Blazar, Kushi Kushekhar, Djamilatou Adom, Rebecca Wu, Katherine E. Lewis, Ryan Swanson, Hao Liu, Samantha Hund, Kristine M. Swiderek, Keli L. Hippen, Amanda Albright, Sophie Paczesny, Maykala Kirksey, Jinfeng Yang, Sherri Mudri, Stanford L. Peng, Erika Rickel, Katherine Henderson, Abdulraouf Ramadan, Lawrence Evans, Titilayo Adeniyan, Stacey R. Dillon, Michelle A. Seaberg, Martin F. Wolfson, Chelsea J. Gudgeon
Publikováno v:
Science Translational Medicine. 12
Acute graft-versus-host disease (aGVHD) remains a major complication of allogeneic hematopoietic cell transplantation (HCT). CD146 and CCR5 are proteins that mark activated T helper 17 (Th17) cells. The Th17 cell phenotype is promoted by the interact
Autor:
Siddarth Chandrasekaran, Demonte Daniel William, Logan Garrett, Stanford L. Peng, Ardourel Daniel F, Katherine E. Lewis, Sherri Mudri, Mark F. Maurer, Kayla N. Kleist, Michelle A. Seaberg, Jing Yang, Steven D. Levin, Mark W. Rixon, Joseph L. Kuijper, Rachel Wang, Stacey R. Dillon, Hieu Nguyen, Chelsea J. Gudgeon, Martin F. Wolfson
Publikováno v:
Cancer Research. 81:1740-1740
Introduction: Checkpoint inhibition (CPI) has been shown to be an effective anti-tumor therapy, but CPI alone is frequently insufficient to control tumor growth, and costimulatory signals may also be required to produce clinically significant anti-tu
Autor:
Djamilatou, Adom, Stacey R, Dillon, Jinfeng, Yang, Hao, Liu, Abdulraouf, Ramadan, Kushi, Kushekhar, Samantha, Hund, Amanda, Albright, Maykala, Kirksey, Titilayo, Adeniyan, Katherine E, Lewis, Lawrence, Evans, Rebecca, Wu, Steven D, Levin, Sherri, Mudri, Jing, Yang, Erika, Rickel, Michelle, Seaberg, Katherine, Henderson, Chelsea J, Gudgeon, Martin F, Wolfson, Ryan M, Swanson, Kristine M, Swiderek, Stanford L, Peng, Keli L, Hippen, Bruce R, Blazar, Sophie, Paczesny
Publikováno v:
Sci Transl Med
Acute graft-versus-host disease (aGVHD) remains a major complication of allogeneic hematopoietic cell transplantation (HCT). CD146 and CCR5 are proteins that mark activated T helper 17 (Th17) cells. The Th17 cell phenotype is promoted by the interact
Autor:
Kristine M. Swiderek, Siddarth Chandrasekaran, Stanford L. Peng, Katherine E. Lewis, Steven D. Levin, Fariha Ahmed-Qadri, Sherri Mudri, Chelsea J. Gudgeon, Kayla N. Kleist, Stacey R. Dillon, Mark F. Maurer
Publikováno v:
Cancer Research. 80:LB-085
Background: Despite significant clinical benefit of checkpoint inhibitors (CPI) in some settings, unfortunately, the majority of patients still fail to respond and/or develop resistance. This is likely due to a complex set of factors including, but n
Autor:
Stacey R. Dillon, Lawrence S. Evans, Susan Bort, Sherri Mudri, Katherine Lewis, Mark Rixon, Janhavi Bhandari, Stanford Peng, Kristine M. Swiderek
Publikováno v:
Gastroenterology. 158:S-786
Autor:
Kristine M. Swiderek, Katherine E. Lewis, Janhavi Bhandari, Stanford L. Peng, John P. Moore, Sherri Mudri, Susan Bort, Mark W. Rixon, Stacey R. Dillon
Publikováno v:
Gastroenterology. 158:S7